|
1) 江石義信. サルコイドーシスの病因. 呼吸. 2000; 19: 764-73
|
|
|
|
2) Hennessy TW, Ballard DJ, DeRemee RA, et al. The influence of diagnostic access bias on the epidemiology of sarcoidosis: a population-based study in Rochester, Minnesota, 1935-1984. J Clin Epidemiol. 1988; 41: 565-70
|
|
|
|
|
3) James DG. Epidemiology of sarcoidosis. Sarcoidosis. 1992; 9: 79-87
|
|
|
|
|
|
4) Access Research Group. Design of a case controlled etiologic study of sarcoidosis (ACCESS). J Clin Epidemiol. 1999; 52: 1173-86
|
|
|
|
|
|
5) Iwai K, Tachibana T, Takemura T, et al. Pathological studies on sarcoidosis autopsy. I. Epidemiological features of 320 cases in Japan. Acta Pathol Jpn. 1993; 43: 372-6
|
|
|
|
|
|
6) 長井苑子. サルコイドーシスの疫学. 日本臨牀. 2002; 60: 1697-703
|
|
|
|
|
|
7) Morimoto T, Azuma A, Abe S, et al. Epidemiology of sarcoidosis in Japan. Eur Respir J. 2008; 31: inpress
|
|
|
|
|
|
8) Baughman RP, Teirstein AS, Judson MA, et al. Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med. 2001; 164: 1885-9
|
|
|
|
|
|
9) Gundelfinger BF, Britten SA. Sarcoidosis in the United States Navy. Am Rev Respir Dis. 1961; 84: 109-15 (suppl)
|
|
|
|
|
|
10) Sartwell PE, Edwars LB. Epidemiology of sarcoidosis in the US Navy. Am J Epidemiol. 1974; 99: 250-7
|
|
|
|
|
|
11) Rybicki BA, Major M, Popovich Jr J, et al. Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization. Am J Epidemiol. 1997; 145: 234-41
|
|
|
|
|